Trials / Completed
CompletedNCT01532427
ALFApump System Post Marketing Surveillance Registry
ALFApump System Post Marketing Surveillance Registry, In Support of the Following Indication: Automated Removal of Excess Peritoneal Fluid Into the Urinary Bladder in Patients With Cirrhosis or Malignancy, With Persistent or Refractory Ascites
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Sequana Medical N.V. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a post market surveillance registry to monitor the safety and performance of the ALFApump system.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2019-07-08
- Completion
- 2019-07-08
- First posted
- 2012-02-14
- Last updated
- 2020-10-26
Locations
13 sites across 4 countries: Germany, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01532427. Inclusion in this directory is not an endorsement.